BTIG Maintains Buy on Abbott Laboratories, Lowers Price Target to $131

Abbott Laboratories

Abbott Laboratories

ABT

0.00

BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE: ABT) with a Buy and lowers the price target from $140 to $131.